The global dietary supplements market size was valued at USD 151.9 billion in 2021 and is expected to reach USD 327.4 billion by 2030 at a CAGR of 8.9% from 2022 to 2030.The demand for dietary supplements is anticipated to increase over the forecast period as a result of changing food patterns and busy lives and growing awareness of personal health and wellness.
The size of the global oleochemicals market is anticipated to reach USD 34.89 billion by 2028, exhibiting a CAGR of 7.57% during the projected period. Major end-use industries including food & beverage, pharmaceuticals, personal care & cosmetics, and plastic & polymers have increased demand for oleochemical derivatives, which can be linked to the market expansion.
The size of the Europe MRO distribution market is anticipated to reach USD 259.16 billion by 2030, exhibiting a CAGR of 2.8%. A number of well-known prominent European sectors have embraced integrated repair, maintenance, and operating service approaches to upgrade their crucial manufacturing activities.
The global cannabidiol market totaled 5.18 billion in 2021 and is anticipated to expand at a CAGR of 16.8% from 2022 to 2030. Cannabidiol is the chemical compound extracted from the cannabis Sativa plant. The cannabidiol-extracted medications have properties that overcome anxiety, reduce pain, and minimize seizures, benefitting the healing treatments.
The U.S. office-based labs market is projected to value USD 18.3 billion by 2030, registering a compound annual growth rate (CAGR) of 7.46% from 2022 to 2030. The U.S. office-based labs market is driven by the rising cases of cardiovascular diseases, particularly Peripheral Artery Diseases (PADs) among the geriatric population.
The global home infusion therapy market reached a valuation of USD 31.0 billion in 2021 and is anticipated to total USD 61.7 billion by 2030. The market is expected to expand at a CAGR of 7.9% from 2022 to 2030. The growth of the market is attributed to the rising adoption of treatments at homes through catheters and needles.
The global education technology market is anticipated to reach USD 429.5 billion by 2030 at a CAGR of 16.5%. The emergence of technology has evolved the learning experience. The education industry is on the verge of the digital revolution.
The global protein supplements market size was totaled USD 6.26 billion in 2021 and is anticipated to grow at a CAGR of 8.0% from 2022 to 2030. The market growth is attributed to the growing awareness regarding health concerns among the larger population.
The global protein ingredients market size totaled USD 38.5 billion in 2020. The market is anticipated to expand at a CAGR of 10.5% from 2021 to 2028. The clinically proven nutritional benefits of protein ingredients products have increased their demand in past few years from the biopharmaceutical industry.
The global next-generation sequencing market size totaled a valuation of USD 4.83 billion in 2021. The market growth is anticipated to witness growth at a CAGR of 12.4% from 2022 to 2030. NSG is a technology with scalability with ultrahigh throughput and high speed to determine nucleotides in the genome.
The global genomics market size is projected to reach USD 94.9 billion by 2030, registering a CAGR of 16.4% during the forecast period from 2022 to 2030. Factors such as increasing demand for gene therapy, drug discovery, customized medicines, and a rise in cancer cases all around the world have positively impacted the genomics market.
The global enterprise governance, risk & compliance market size is expected to reach USD 134.8 billion by 2030, expanding at a CAGR of 14.0% during the forecast period from 2022 to 2030. Growing data and security breaches, rising stringent compliance mandates, and integration of AI and blockchain technologies in GRC solutions are some of the driving factors of the global enterprise governance, risk & compliance market growth.
The global aerosol market size is expected to reach USD 131.9 billion in 2030, registering a CAGR of 6.6% during the forecast years from 2022 to 2030. The increasing demand for aerosol-based products like household, personal care, medical, industrial, and automotive products from various end-use industries is expected to drive market growth significantly.
The global hospital gowns market size was worth USD 4.3 billion in 2021 which is projected to expand at a CAGR of 12.88% and reach USD 12.8 billion by 2030. Factors like a surge in incidents of healthcare-associated infections (HAIs) on the account of inadequate sanitation and precautionary measures and an increase in the number of surgeries are constituted to drive the market growth in the forecast period.
The global wound care market is expected to reach USD 29.6 billion by 2030, expanding at a CAGR of 4.1% during the forecast period from 2022 to 2030. The major factors positively influencing the market growth of wound care include the rapid increase in the aging population, the growing number of surgical cases, and the rise in the number of diabetic patients globally.
The global omega-3 market size was USD 2.10 billion in 2020 which is anticipated to reach USD 3.82 billion by 2028. Primary reasons for the growth include the prevalence of cardiovascular diseases (CVDs), changes in dietary habits, and a focus on immunity development.
The global eClinical solutions market was valued at USD 7.2 billion in 2021 and is likely to value at USD 21.8 billion by 2030, advancing at a CAGR of 13.6% from 2022 to 2030. The high prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes, along with the discovery of new infections now and then has supplemented the need for robust R&D in the pharma and biopharma industry.
The global single-use bioprocessing market size was valued at USD 19.36 billion in the year 2021 and is expected to cross USD 79.47 billion by 2030, registering a CAGR of 16.6% during the period in focus. The rising use of single-use bioprocessing technology in the vast biopharmaceuticals industry over the years along with rising investments made toward the development of biologics like vaccines, recombinant proteins, monoclonal antibodies, and a number of others will continue to drive the business scope in the times to come.
The global pharmacovigilance market size was USD 6.82 billion in 2021 which is projected to expand at a CAGR of 9.3% and reach USD 13.9 billion by 2030. The primary reason for this growth constitutes the rise in oncological, cardiovascular, and respiratory disorders, and diabetes. Therefore, there has been a surge in the consumption of drugs across the world, which resulted in an increased demand for pharmacovigilance.
The global digital signage market size is projected to reach USD 45.33 billion by 2030, advancing steadily at 7.7% CAGR during the assessment period. The continued growth of the commercial and industrial sectors in developed and developing nations has created significant growth opportunities for companies in this industry